TrialHaematologica2010

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Maria Domenica Cappellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.